Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1–50 of 77097
On October 5, 2026, Brent Pope notified AgEagle Aerial Systems Inc. (the “Company”) of his intention to retire from his position as Chief Operating Officer of the Company, effective November 30, 2026.
On October 6, 2026, the Board of Directors (the “Board”) of Sidus Space, Inc. (the “Company”) received the resignation letter of Tiffany Norwood, pursuant to which Ms. Norwood resigned from the Board and as Audit Committee Chairwoman and as a member of the Corporate Governance/Nominating Committee, effective October 6, 2026 at 7:15 p.m. ET.
On October 6, 2026, the Board of the Company received the resignation letter of Kelle Wendling, pursuant to which Ms. Wendling resigned from the Board and as a member of the Audit Committee, Compensation Committee and Corporate Governance/Nominating Committee, effective October 6, 2026 at 1:00 p.m. ET.
On October 5, 2026, Mr. Chad Corbin notified Ross Tannenbaum, the Chief Executive Officer of NextBoat Inc. (the “Company”), of his decision to resign as Chief Financial Officer (the “CFO”) of the Company. Mr. Corbin will continue to serve as CFO during a transition period until a successor CFO is identified. Mr. Corbin’s resignation did not result from any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
The employment of Michael Fiore, the Chief Commercial Officer at HealthEquity, Inc. (the “Company”), was terminated by the Company without cause, effective October 5, 2026.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.
In accordance with Section 2.10 of the Merger Agreement, at the Effective Time, each of Clifford L. Neuman, Kent J. Lund, and Richard Huebner ceased to serve as a member of the Board of Directors of the Company (the “Board”) and of any committee of the Board, and Krystal Eckhart ceased to serve as Interim Chief Financial Officer of the Company.
On October 9, 2026, William H. White was terminated as Chief Financial Officer and Principal Financial Officer of Quantum Corporation (the “Company”) effective immediately.
On October 9, 2026, Mitek Systems, Inc. (the “Company”), announced that the employment of Michael E. Diamond, Senior Vice President of Sales, Check Verification and one of the Company’s named executive officers for fiscal year 2026, will terminate on December 8, 2026.
On October 8, 2026, Fluence Energy, Inc. (“the Company”, “we” or “our”) and Peter Williams, our former Senior Vice President and Chief Product Officer, entered into a separation agreement and release of claims (the “Williams Separation Agreement”).
On October 9, 2026, Brian Dostie, principal accounting officer of BARK, Inc. (the “Company”), notified the Company of his decision to resign from the Company, effective October 23, 2026, to pursue another professional opportunity. Mr. Dostie ceased serving as the Company’s principal accounting officer effective October 9, 2026.
The Consents, in part, removed from the Company’s Board of Directors (the “Board”) without cause each of Daniel Lewis, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan and Harit Talwar, effective immediately (the “Removal”).
The Consents, in part, removed from the Company’s Board of Directors (the “Board”) without cause each of Daniel Lewis, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan and Harit Talwar, effective immediately (the “Removal”).
On October 1, 2026, Hugh Frater notified the Company of his decision to resign from the Board, effective upon the Removal. Mr. Frater’s decision to resign was the result of the outcome of the consent solicitation conducted by the Garg Group to remove without cause certain other directors from the Board, as further described in this Current Report on Form 8-K.
On October 5, 2026, following the director appointments described above, the Board removed Daniel Lewis as Interim Chief Executive Officer, effective immediately. The Board has commenced a process to identify and appoint a successor Interim Chief Executive Officer.
The Consents, in part, removed from the Company’s Board of Directors (the “Board”) without cause each of Daniel Lewis, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan and Harit Talwar, effective immediately (the “Removal”).
The Consents, in part, removed from the Company’s Board of Directors (the “Board”) without cause each of Daniel Lewis, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan and Harit Talwar, effective immediately (the “Removal”).
The Consents, in part, removed from the Company’s Board of Directors (the “Board”) without cause each of Daniel Lewis, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan and Harit Talwar, effective immediately (the “Removal”).
On October 6, 2026, Myriad Genetics, Inc. (the “Company”) entered into a Separation Agreement and Release of Claims (the “Separation Agreement”) with Brian Donnelly, the Company’s former Chief Commercial Officer. As previously disclosed, Mr. Donnelly departed from his position as Chief Commercial Officer of the Company, effective September 16, 2026.
On October 6, 2026, Donna F. Zarcone informed the Board of Directors (the “Board”) of The Cigna Group (the “Company”) that she will retire from the Board effective December 31, 2026.
On October 9, 2026, W. Kimball Griffith informed the Board of Managers (the “ Board ”) of Greystone AF Manager LLC, a Delaware limited liability company (the “ Company ”), of his decision to retire as a member of the Board of the Company, effective as of October 9, 2026.
On October 9, 2026, following the completion of Phoenix Education Partners, Inc.’s (the “Company”) first full year as a public company after its successful IPO, the Company and Blair Westblom, Chief Financial Officer and Treasurer of the Company, agreed that Ms. Westblom will separate from the Company, effective as of October 10, 2026, to focus on personal endeavors and her next professional chapter.
previously reported resignation of Katharyn Field as a director effective August 31, 2026.
As previously disclosed in a Current Report on Form 8-K filed by Pool Corporation (“the Company”) on January 12, 2026, Kenneth G. St. Romain informed the company of his decision to retire as Senior Vice President at a future unspecified date during 2026. On October 5, 2026, the Company announced the effective date of Mr. St. Romain’s retirement as Senior Vice President as December 31, 2026.
On October 8, 2026, Helder Antunes tendered his resignation as a director of Veea Inc. (the “ Company ”), effective immediately, and Mr. Antunes will continue to serve as an Executive Vice President and Chief Revenue Officer of the Company.
On October 6, 2026, Aidin Aghamiri notified Plum Acquisition Corp. IV (the “Company”) of his resignation as a member of the Company's board of directors (the “Board”), effective immediately. Mr. Aghamiri's resignation was not the result of any disagreement with the Company or the Board on any matter relating to the Company's operations, policies or practices.
Richard Gorman resigned from the Board of Directors (“Board”) of the Company and from all committees of the Board on which he served, including the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee, effective October 12, 2026.
Effective upon the closing at 12:00 p.m. Eastern Time on October 6, 2026, Brito resigned as Chief Executive Officer and as a member of the Company’s Board of Directors. His resignation was voluntary and was not the result of any disagreement with the Company concerning its operations, policies or practices.
On October 5, 2026, The Marzetti Company (the “Company”) announced that Tanya Berman, President of Retail Division of T. Marzetti Company, a subsidiary of the Company, is no longer serving in this role effective October 6, 2026.
On October 6, 2026, Samantha Pearce, Executive Vice President, Chief Commercial Officer of Jazz Pharmaceuticals plc (the “Company” ), notified the Company of her intent to retire from her role as Chief Commercial Officer upon the earlier of the selection and appointment of her successor or by June 30, 2027.
On October 8, 2026, Erika Fisher, the Chief Legal Officer and Corporate Secretary of HubSpot, Inc. (the "Company"), notified the Company of her decision to resign from the Company, effective November 6, 2026, to pursue another professional opportunity.
Humphrey Polanen resigned from the Company’s Board of Directors effective on such date. Mr. Polanen’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
In connection with the foregoing, on October 8, 2026, Ms. Lawrence tendered her resignation from the Board and from the Compensation Committee of the Board, effective immediately prior to the Appointment Date and Time. Following the effective time of her resignation, Ms. Lawrence will serve as a non-voting observer to the Board until she is re-appointed to the Board immediately following the conclusion of the 2026 Annual Meeting. Ms. Lawrence’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
effective as of October 8, 2026, Dirk Thye, M.D., resigned as Chief Executive Officer and Chief Medical Officer, as well as a director, of Quince Therapeutics, Inc.
Brendan Hannah resigned as Chief Operating Officer, Chief Business Officer and Chief Compliance Officer of the Company.
Mr. Frank succeeds Dr. Ashish K. Khandpur, who will continue to provide advisory consulting support through 2026.
On October 9, 2026, Victoria’s Secret & Co. (the “Company”) announced that Melinda McAfee, Chief Legal and Compliance Officer, will be leaving the Company, effective March 31, 2027.
On October 08, 2026, Brogan Ptacin, Executive Vice President and Head of Commercial Banking, and a named executive officer of the Company, provided notice of his decision to retire from his position effective December 31, 2026. Following his retirement, Mr. Ptacin will be employed by the Bank in a non-executive, part-time, advisory capacity for a period of time to be determined.
On October 08, 2026, Mark Fucinato, Executive Vice President and Chief Credit Officer, provided notice of his decision to retire from his position effective December 31, 2026.
The description of the expected resignations of Kristi H. McCarthy, Kristen M. Ghattas, Barbara F. Harrison and Gerbert Schoonman as directors of GP LLC at Closing included under “Amendments to Existing Governing Documents” in Item 1.01 is hereby incorporated by reference.
The description of the expected resignations of Kristi H. McCarthy, Kristen M. Ghattas, Barbara F. Harrison and Gerbert Schoonman as directors of GP LLC at Closing included under “Amendments to Existing Governing Documents” in Item 1.01 is hereby incorporated by reference.
The description of the expected resignations of Kristi H. McCarthy, Kristen M. Ghattas, Barbara F. Harrison and Gerbert Schoonman as directors of GP LLC at Closing included under “Amendments to Existing Governing Documents” in Item 1.01 is hereby incorporated by reference.
The description of the expected resignations of Kristi H. McCarthy, Kristen M. Ghattas, Barbara F. Harrison and Gerbert Schoonman as directors of GP LLC at Closing included under “Amendments to Existing Governing Documents” in Item 1.01 is hereby incorporated by reference.
As previously disclosed in the Prior 8-K, Directors Ahmet C. Dorduncu and Kathryn D. Sullivan notified the Board of their intention to retire from Board service effective December 31, 2026.
As previously disclosed in the Prior 8-K, Directors Ahmet C. Dorduncu and Kathryn D. Sullivan notified the Board of their intention to retire from Board service effective December 31, 2026.
On October 5, 2026, John Jubilee notified I-ON Digital Corp. (the “Company”) of his intention to resign as a Director of the Company, effective immediately. Mr. Jubilee’s resignation is not the result of any disagreement between Mr. Jubilee and the Company on any matter relating to the Company’s operations, policies or practices.
On October 2, 2026, Barak Eilam provided Payoneer Global Inc. (the “Company”) with notice of his decision to resign as a director of the Board of Directors (the “Board”) of the Company. Mr. Eilam’s resignation became effective October 5, 2026 (the “Effective Date”).
On October 7, 2026, Judy Lin, a member of the Board, notified the Company of her decision to retire from the Board. Her service on the Board will conclude on October 9, 2026.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.